Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 232

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Multiple Cerebral Hemorrhages in a Patient Receiving Lecanemab and Treated with t-PA for Stroke

Open access
Reish, Nicholas J., Jamshidi, Pouya, Stamm, Brian, Flanagan, Margaret E., Sugg, Elizabeth, Tang, Mengxuan, Donohue, Kelly L., McCord, Matthew, Krumpelman, Chase, Mesulam, Marek-Marsel, Castellani, Rudolph, Chou, Sherry H.-Y. · 2023 · New England Journal of Medicine

Abstract

The results of the phase 3 trial of the anti-amyloid-β drug lecanemab for the treatment of early Alzheimer's disease, reported in the Journal by van Dyck et al., 1 have suggested a beneficial effect on cognition scores and daily activities over a period of 18 months.An extension phase of the trial is ongoing.We report a case of numerous acute intracerebral hemorrhages that developed after treatment with intravenous tissue plasminogen activator (t-PA) for acute ischemic stroke syndrome in a patient who received three doses of intravenous lecanemab.A 65-year-old patient who was homozygous for the APOE ε4 allele and was in the early stages of cognitive decline presented to an emergency department 30 minutes after the acute onset of aphasia and left gaze preference due to an ischemic stroke.The patient had participated in the randomized phase of the trial of lecanemab, during which the treatment assignment is not known, followed by participation in the open-label phase, in which three intravenous lecanemab infusions were received (one infusion every 2 weeks), with the latest infusion administered 4 days before the stroke.Magnetic resonance imaging (MRI) of the head that had been performed 81 days before the stroke showed mild small-vessel disease, with no microhemorrhages, edema, or amyloid-related imaging abnormalities (Figs.sherry.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1056/nejmc2215148

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Cited by

See all 232

Metadata

Authors
Reish, N. J., Jamshidi, P., Stamm, B., Flanagan, M. E., Sugg, E., Tang, M., Donohue, K. L., McCord, M., Krumpelman, C., Mesulam, M.-M., Castellani, R., & Chou, S. H.-Y.
Venue
New England Journal of Medicine
Published
2023-02-02
Volume
388
Issue
5
Pages
478-479
ISSN
  • 0028-4793 (ISSN-L)
  • 1533-4406
OpenAlex
W4313546276
Cited by
232
References
1
FWCI
33.75
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Multiple Cerebral Hemorrhages in a Patient Receiving Lecanemab and Treated with t-PA for Stroke. https://app.cochat.ai/papers/10.1056/nejmc2215148
The paper
Reish, N. J., Jamshidi, P., Stamm, B., Flanagan, M. E., Sugg, E., Tang, M., Donohue, K. L., McCord, M., Krumpelman, C., Mesulam, M.-M., Castellani, R., & Chou, S. H.-Y. (2023). Multiple Cerebral Hemorrhages in a Patient Receiving Lecanemab and Treated with t-PA for Stroke. New England Journal of Medicine. https://doi.org/10.1056/nejmc2215148

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.